IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
70
Frequently Asked Questions
What is Market Cap of IGC Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. IGC Pharma Inc market cap is $39.38M.
What is the 52-week high for IGC Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IGC Pharma Inc 52 week high is $0.4985 as of September 07, 2025.
What is the 52-week low for IGC Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IGC Pharma Inc 52 week low is $0.2525 as of September 07, 2025.
What is IGC Pharma Inc stock price today?
IGC Pharma Inc stock price today is $0.4337.
What was IGC Pharma Inc stock price yesterday?
IGC Pharma Inc stock price yesterday was $0.438.
What is the PE ratio of IGC Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. IGC Pharma Inc’s P/E ratio is -5.41.
What is the Price-to-Book ratio of IGC Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. IGC Pharma Inc P/B ratio is 6.0036.
What is the 50-day moving average of IGC Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. IGC Pharma Inc 50-day moving average is $0.3659.
IGC IGC Pharma Inc